• Neurelis Announces Four Poster Presentations For The Joint Meeting Of The International Child Neurology Association And Child Neurology Society

    11 days ago - By San Diego Biotechnology

    Data continue to support the unique clinical attributes for Neurelis' lead product, VALTOCO® , the first and only nasal spray treatment for seizure cluster rescue in pediatric patients 6 years of age and older, adolescents, and......
    Read more ...